Royalty Pharma plc (LS:A2P62D) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ted W Love Other companies: Lisata Therapeutics, Inc. (Director · Since at least Sep 17, 2026); Jazz Pharmaceuticals plc (Director · Since at least Dec 1, 2025); Gilead Sciences, Inc. (Director · Since at least Feb 1, 2024); Structure Therapeutics, Inc. (Director · Since at least Aug 3, 2023); Seagen Inc (Director · Aug 16, 2020 – Dec 14, 2023 · Past); Portola Pharmaceuticals Inc (Director · Sep 18, 2019 – Jul 2, 2020 · Past); Global Blood Therapeutics Inc (President and CEO, Director · Aug 11, 2015 – Oct 5, 2022 · Past); Cascadian Therapeutics Inc (Director · Sep 5, 2013 – Mar 9, 2018 · Past); Savara, Inc. (Director · Sep 5, 2012 – Jun 19, 2013 · Past); Humanigen Inc (Director · Aug 10, 2012 – Jul 10, 2015 · Past); Amicus Therapeutics Inc (Director · Jun 13, 2012 – Jun 4, 2020 · Past); Bio-Rad Laboratories, Inc. (Director · Mar 24, 2010 – Mar 24, 2010 · Past); Onyx Pharmaceuticals Inc (EVP, R&D and Tech. Operations · Feb 1, 2010 – Jul 25, 2012 · Past); Affymax Inc (Director · Dec 14, 2006 – Jun 13, 2012 · Past); Santarus Inc (Director · Jun 7, 2006 – Jan 2, 2014 · Past); Oruka Therapeutics, Inc. (Director · Mar 7, 2006 – Feb 5, 2010 · Past) | Director · Since at least Jul 30, 2020 |
| Vlad Coric Other companies: Veradermics, Incorporated (Board Member · Since at least Feb 3, 2026); Biohaven Ltd. (Chairman & Chief Executive Officer · Since at least Sep 22, 2022); Revance Therapeutics, Inc. (Director · Mar 1, 2023 – Feb 4, 2025 · Past); Akili Inc (Director · Jun 29, 2021 – Jun 29, 2021 · Past); Biohaven Pharmaceutical Holding Co Ltd (Chief Executive Officer, Director · May 3, 2017 – Oct 3, 2022 · Past) | Director · Since at least Apr 7, 2025 |
| Carole Ho Other companies: Eli Lilly and Company (Executive Vice President and President, Lilly Neuroscience · Since at least Dec 31, 2025); Beam Therapeutics Inc. (Director · Since at least Feb 5, 2020); Denali Therapeutics Inc. (Chief Medical Officer · Since at least Apr 1, 2019); NGM Biopharmaceuticals Inc (Director · Jun 5, 2020 – Apr 5, 2024 · Past) | Director · Since at least Jul 17, 2025 |
| Elizabeth Weatherman Other companies: Insulet Corporation (Director · Since at least May 22, 2024); Silk Road Medical Inc (Director · Jun 18, 2024 – Sep 17, 2024 · Past); Vapotherm Inc (Director · Jan 1, 2024 – Sep 20, 2024 · Past); Nevro Corp (Director · Sep 30, 2023 – Apr 3, 2025 · Past) | Director · Since at least Jul 17, 2025 |
| Gregory Norden Other companies: Praxis Precision Medicines, Inc. (Director · Since at least Oct 15, 2020); Zoetis Inc. (Director · Since at least Feb 11, 2020); Entasis Therapeutics Holdings Inc (Director · Jun 19, 2019 – Jun 19, 2019 · Past); NanoString Technologies Inc (Director · Jun 18, 2019 – May 6, 2024 · Past) | Director · Since at least Jun 15, 2020 |
| Bonnie Bassler Other companies: Cidara Therapeutics Inc (Director · Since at least Jan 22, 2021); Regeneron Pharmaceuticals, Inc. (Chair, Department of Molecular Biology, and Squibb Professor in Molecular Biology, Princeton University · Since at least Sep 9, 2016); Kaleido Biosciences, Inc. (Director · Feb 27, 2019 – Jun 30, 2021 · Past) | Board Member · Since at least Jun 15, 2020 |
| Christopher Hite Other companies: Kailera Therapeutics, Inc. (Independent Board Member · Since at least Apr 16, 2026); Vera Therapeutics, Inc. (EVP and Vice Chairman, Royalty Pharma · Since at least Mar 5, 2026); Acceleron Pharma Inc (Director · Jun 4, 2020 – Nov 19, 2021 · Past) | EVP & Chairman, Partnering · Since at least Jun 15, 2020 |
| Rory Riggs Other companies: Cibus, Inc. (Director · Since at least May 31, 2023); Kyntra Bio, Inc. (Director · Nov 13, 2014 – May 26, 2021 · Past); Intra-Cellular Therapies Inc (Director · Jan 8, 2014 – Apr 2, 2025 · Past) | Director · Jun 15, 2020 – Feb 20, 2024 · Past |
| David C. Hodgson Other companies: Alignment Healthcare, Inc. (Director · Since at least Mar 26, 2021); TriNet Group, Inc. (Director · Since at least Mar 21, 2014) | Vice Chairman · Since at least Jun 23, 2022 |
| Errol B Desouza Other companies: Alector, Inc. (Director · Since at least Mar 19, 2024); Cyclerion Therapeutics, Inc. (Director · Nov 30, 2023 – Nov 30, 2023 · Past) | Director · Jun 7, 2024 – May 13, 2025 · Past |
| Pablo Legorreta Other companies: ProKidney Corp. (Chairman of the Board · Since at least Jul 11, 2022); Epizyme Inc (Director · Nov 6, 2019 – Aug 12, 2022 · Past) | Founder & Chief Executive Officer · Since at least Jun 15, 2020 |
| Ted W. Love Other companies: Gilead Sciences, Inc. (Director · Since at least May 4, 2026); Jazz Pharmaceuticals plc (Director, Jazz Pharmaceuticals plc · Since at least Nov 5, 2025) | Board Member · Since at least Sep 29, 2025 |
| William E Ford Other companies: BlackRock, Inc. (Director · Since at least Sep 30, 2020); Ihs Markit Ltd (Director · Dec 15, 2020 – Feb 28, 2022 · Past) | Director · Oct 20, 2020 – Jun 30, 2021 · Past |
| Catherine M Engelbert Other companies: McDonald's Corporation (Director · Since at least Dec 31, 2023) | Director · Since at least Jun 7, 2024 |
| Greg Norden Other companies: Praxis Precision Medicines, Inc. (Director · Since at least Jun 12, 2026) | Board Member · Since at least Jun 8, 2026 |
| Henry A. Fernandez Other companies: MSCI Inc. (Chairman and CEO, Director · Since at least Feb 8, 2023) | Director · Since at least Mar 31, 2022 |
| Arthur McGivern | General Counsel & Investments · Since at least Jan 1, 2026 |
| Cathy Engelbert | Board Member · Since at least Jun 8, 2026 |
| Eric Schneider | Chief Technology Officer · Since at least Nov 4, 2026 |
| George W Lloyd | EVP, Investments & CLO · Since at least Jun 15, 2020 |
| Greg Raskin | Head of Academic Initiatives · Since at least Aug 3, 2026 |
| James F Reddoch | EVP & Chief Scientific Officer · May 19, 2022 – Sep 28, 2022 · Past |
| Jim Reddoch | Chief Scientific Officer & Investments · Since at least Nov 4, 2026 |
| Kenneth Sun | Head of Asia · Since at least Mar 3, 2026 |
| Lucas Glass | Head of Artificial Intelligence · Since at least Mar 23, 2026 |
| Mario Germano Giuliani | Director · Jun 15, 2020 – Jun 23, 2023 · Past |
| Marshall Urist | Head of Research & Investments · Since at least Aug 12, 2024 |
| Nick Montemarano | Executive Director, Investor Relations · Since at least Mar 27, 2026 |
| Scott Raichilson | Chief Accounting Officer · Since at least Nov 5, 2026 |
| Terrance Coyne | Chief Financial Officer · Since at least Aug 12, 2024 |